Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
litigation
Manufacturing
WuXi AppTec wins temporary relief in DOD classification feud
Chief Judge James Boasberg said WuXi AppTec had made a reasonable case that the Defense Department acted in an “arbitrary and capricious” manner.
Fraiser Kansteiner
Aug 11, 2026 11:33am
Gilead prevails in yearslong HIV drug innovation case
Aug 4, 2026 3:00pm
Sandoz inks dual settlements to resolve most US antitrust claims
Aug 3, 2026 10:18am
GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement
Nov 21, 2025 9:46am
Fierce Biotech
FibroGen pays SEC $1.2M over claims of 'reverse engineered' data
Sep 11, 2025 10:41am
University of Michigan seeks damages over AZ's FluMist sales
Aug 29, 2025 10:15am
